NASDAQ:VTRS Viatris (VTRS) Stock Price, News & Analysis $20.67 -0.39 (-1.85%) Closing price 04:00 PM EasternExtended Trading$20.79 +0.12 (+0.58%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Viatris Stock (NASDAQ:VTRS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Viatris alerts:Sign Up Key Stats Today's Range$20.65▼$21.2050-Day Range$16.38▼$21.0652-Week Range$10.15▼$21.20Volume8.79 million shsAverage Volume9.68 million shsMarket Capitalization$23.70 billionP/E RatioN/ADividend Yield2.32%Price Target$21.11Consensus RatingModerate Buy Company Overview Viatris Inc. is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, Pfizer’s off-patent branded and generics business. The company develops, manufactures and markets medicines for patients around the world. Its portfolio includes generic and branded medicines, complex generics and biosimilars, as well as active pharmaceutical ingredients. Viatris products address a range of therapeutic areas, including cardiovascular disease, infectious diseases, oncology and central nervous system conditions. Headquartered in Canonsburg, Pennsylvania, Viatris serves patients and healthcare providers in more than 165 countries and territories. Scott A. Smith became the company’s chief executive officer in 2023.AI Generated. May Contain Errors. Read More Viatris Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreVTRS MarketRank™: 2.51826722338 of 5 starsViatris scored higher than 50% of companies evaluated by MarketBeat, and ranked 572nd out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingModerate Buy Consensus RatingViatris has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 7 buy ratings, 2 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Viatris is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageViatris has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Viatris' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth6.56% Earnings GrowthEarnings for Viatris are expected to grow by 6.56% in the coming year, from $2.59 to $2.76 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Viatris is -39.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Viatris is -39.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioViatris has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioViatris has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.08% of the float of Viatris has been sold short.Short Interest Ratio / Days to CoverViatris has a short interest ratio ("days to cover") of 4.04.Change versus previous monthShort interest in Viatris has recently decreased by 7.08%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldViatris pays a meaningful dividend of 2.34%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthViatris does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Viatris will have a dividend payout ratio of 17.39% next year. This indicates that Viatris will be able to sustain or increase its dividend.Read more about Viatris' dividend. News and Social Media2.8 / 5News Sentiment0.53 News SentimentViatris has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Viatris this week, compared to 5 articles on an average week.Search InterestOnly 7 people have searched for VTRS on MarketBeat in the last 30 days. This is a decrease of -42% compared to the previous 30 days.MarketBeat Follows7 people have added Viatris to their MarketBeat watchlist in the last 30 days. This is an increase of 40% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Viatris insiders have not sold or bought any company stock.Percentage Held by Insiders0.28% of the stock of Viatris is held by insiders.Percentage Held by Institutions79.88% of the stock of Viatris is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Viatris' insider trading history. Receive VTRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viatris and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VTRS Stock News HeadlinesViatris Named to Fortune's World's Best Workplaces™ List for Second Consecutive YearNovember 12 at 8:00 AM | prnewswire.comViatris to Participate in Upcoming Investor ConferencesNovember 11 at 6:59 AM | prnewswire.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 12 at 1:00 AM | Weiss Ratings (Ad)Viatris (VTRS) Earnings Beat And Higher Outlook Put Fair Value Back In FocusNovember 8, 2026 | uk.finance.yahoo.comViatris (VTRS) Stock May Be Below Fair Value Despite A $1.65B DealNovember 8, 2026 | finance.yahoo.comViatris (VTRS) Stock Forecast & Price TargetNovember 6, 2026 | tipranks.comAre Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?November 6, 2026 | finance.yahoo.comVTRS Q3 2026 deep dive: new product launches and Pacira acquisition shape outlookNovember 6, 2026 | msn.comSee More Headlines VTRS Stock Analysis - Frequently Asked Questions How have VTRS shares performed this year? Viatris' stock was trading at $12.45 at the beginning of 2026. Since then, VTRS stock has increased by 66.0% and is now trading at $20.67. How were Viatris' earnings last quarter? Viatris Inc. (NASDAQ:VTRS) issued its quarterly earnings data on Thursday, November, 5th. The company reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of $0.64 by $0.07. Viatris's revenue for the quarter was down .3% compared to the same quarter last year. Read the conference call transcript. Who are Viatris' major shareholders? Top institutional investors of Viatris include State Street Corp (4.05%), First Trust Advisors LP (0.32%), Russell Investments Group Ltd. (0.29%) and Pictet Asset Management Holding SA (0.20%). Insiders that own company stock include Rajiv Malik, Paul Campbell, Scott Andrew Smith, Anthony Mauro, Brian Roman, Xiangyang (Sean) Ni, Dillon Joellen Lyons, Goff Corinne Le, Andrew Cuneo and David S Simmons. View institutional ownership trends. How do I buy shares of Viatris? Shares of VTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Viatris own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viatris investors own include Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Intel (INTC), Verizon Communications (VZ), AbbVie (ABBV) and ExxonMobil (XOM). Company Calendar Record date for 9/16 Dividend8/21/2026Ex-Dividend for 9/16 Dividend8/21/2026Dividend Payable9/16/2026Last Earnings11/05/2026Today11/12/2026UBS Global Biopharma Conference 202611/17/2026Jefferies Global Healthcare Conference11/18/2026Record date for 12/16 Dividend11/23/2026Ex-Dividend for 12/16 Dividend11/23/20269th Annual Evercore ISI HealthCONx Conference12/01/2026Dividend Payable12/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 VTRS's financial health is in the Green zone, according to TradeSmith. VTRS has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:VTRS CIK1792044 Webwww.viatris.com Phone(724) 514-1800Fax724-514-1870Employees30,000Year Founded2020Price Target and Rating Average Price Target for Viatris$21.11 High Price Target$26.00 Low Price Target$14.00 Potential Upside/Downside+2.1%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)($0.53) Trailing P/E RatioN/A Forward P/E Ratio7.49 P/E Growth2.26Net Income-$3.51 billion Net Margins-4.13% Pretax Margin-3.57% Return on Equity20.82% Return on Assets8.30% Debt Debt-to-Equity Ratio0.85 Current Ratio1.55 Quick Ratio0.97 Sales & Book Value Annual Sales$14.30 billion Price / Sales1.66 Cash Flow$7.25 per share Price / Cash Flow2.85 Book Value$11.94 per share Price / Book1.73Miscellaneous Outstanding Shares1,146,450,000Free Float1,143,245,000Market Cap$23.70 billion OptionableOptionable Beta0.89 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:VTRS) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | SponsoredProfessor Who Lectured at Harvard Warns: Sell These 10 Stocks Before Dec. 10Joel Litman, a professor who has lectured at Harvard and Wharton, is warning of a $33 trillion grid crisis tha...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viatris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viatris With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
